Location History:
- Munchen, DE (2000)
- München, DE (2003)
Company Filing History:
Years Active: 2000-2003
Title: The Innovations of Hans A Thoma
Introduction
Hans A Thoma is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 7 patents, his work has had a profound impact on public health.
Latest Patents
One of his latest patents involves the Hepatitis B surface antigen vaccine. This vaccine utilizes HBV surface antigen particles that are prepared by recombinant DNA technology. The particles are composed of epitopes from a group of surface peptides and/or core peptides of non-A, non-B hepatitis viruses, hepatitis A virus, or hepatitis B virus. These particles are characterized by a composition of different epitopes selected from pre-S and S peptides. Additionally, the patent describes DNA sequences, plasmids, and cell lines that code for the respective HBV surface antigen particles, as well as a new vaccine containing these elements.
Career Highlights
Hans A Thoma has been associated with Medeva Holdings Bv, where he has furthered his research and development efforts. His work in the company has been instrumental in advancing vaccine technology and addressing viral infections.
Conclusion
Hans A Thoma's contributions to vaccine development, particularly in the area of Hepatitis B, highlight his innovative spirit and dedication to improving public health. His patents reflect a commitment to scientific advancement and the betterment of society.